secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001193125-25-098597
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio raises ~$1.9M via warrant exercises/exchanges at reduced prices; Series B warrant strike cut to $0.45
--------------------------------------------------------------------------------

- Warrant exercises for 7,178,934 Series A and 2,142,147 Series B shares at $0.1844 (insiders) or $0.1784 (others) per share.
- Warrant exchanges: 656,208 Series A and 574,241 Series B surrendered for pre-funded warrants at $0.0001 exercise price.
- Total expected gross proceeds of ~$1.9 million from the transactions.
- Series B warrant exercise price amended from $1.50 to $0.45 for holders not participating in exercises.
- Transactions must close by May 2, 2025; warrants unexercised by then will terminate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525098597/0001193125-25-098597-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525098597/d597671d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-098597

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer